MinorGlucocorticoids×Serotonin antagonist and reuptake inhibitor (SARI) antidepressant
Updated · Methodology
Mechanism
Prednisolone is metabolised in the liver and excreted in the urine mainly as conjugates. Some corticosteroids are broken down by CYP3A4, so inhibitors and inducers of this enzyme change their concentrations (prednisolone SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Trazodone is also broken down in the liver mainly by CYP3A4 (Deprax SmPC, AEMPS), but no document describes either trazodone or prednisolone as an inhibitor or inducer of this enzyme. No document names the pair. An indirect link is possible through potassium. Prednisolone, especially after prolonged use of relatively high doses, increases potassium excretion and can cause hypokalaemia (prednisolone SmPC, AEMPS). Trazodone prolongs the QT interval, and its use should be avoided in hypokalaemia (trazodone label, US Food and Drug Administration, FDA).
Symptoms
The documents describe no symptoms linked to this combination. Trazodone can lower blood pressure, up to fainting on standing, and can cause drowsiness, QT prolongation and heart rhythm disturbances, and very rarely priapism (Deprax SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Prednisolone can cause sodium and water retention, raise blood pressure and blood glucose and lower potassium, and rarely causes euphoria, mood swings, severe depression or psychosis (prednisolone SmPC, AEMPS).
Management
Trazodone is prescribed for depression (Deprax SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Except as replacement or emergency therapy, prednisolone is not used in known psychiatric disorders such as emotional instability or psychotic tendencies, because they may worsen (prednisolone SmPC, AEMPS). Prednisolone itself can cause mood swings and severe depression (Orapred ODT label, US Food and Drug Administration, FDA). Otherwise, according to the documents, the combination is acceptable, and the doses of prednisolone and trazodone need no change. No document names the pair. During prolonged treatment with relatively high doses of prednisolone, serum potassium is monitored, adequate potassium intake is ensured and sodium is restricted (prednisolone SmPC, AEMPS). Trazodone should be avoided in hypokalaemia and hypomagnesaemia, and in heart disease it is used with caution and close monitoring (trazodone label, FDA). A prolonged course of prednisolone is not stopped abruptly. The dose is reduced gradually (prednisolone SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Orapred ODT (prednisolone sodium phosphate) prescribing information (2025)– FDA label, DailyMed setid 1e379543-c4cf-4e72-953b-db15b7f0c2a1, version 12, revised 06/2025, section 7 NSAIDs, including aspirin and salicylates
- AEMPS: Ficha técnica: Prednisolona (nº registro 84003), sección 4.4 (2026)– AEMPS, CIMA, nº registro 84003, revisión 04/2026, sección 4.4
- FDA: RALDESY (trazodone hydrochloride) prescribing information (2026)– FDA, DailyMed setid 34708cc1-b0b2-4fd0-b9f3-7f008b457fc9 (Validus), revisión 09/2026 (versión 6), secciones 5.2, 5.3, 5.9 y 7
- AEMPS: Ficha técnica: Trazodona, Deprax 100 mg (nº registro 78762), sección 4.5 (2023)– AEMPS, CIMA, nº registro 78762 (Deprax 100 mg comprimidos recubiertos con película, Angelini Pharma España), revisión 11/2023, secciones 4.4, 4.5 y 5.1